Company / SG&A per Share
Quest Diagnostics SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$17.41
FY2025
5-year range
$10.71 / $17.41
FY2021-FY2025
Trend
+16.0%
vs FY2024
Sector context
#26 of 156
Health Care
What the data says
Quest Diagnostics's sg&a per share of $17.41 is higher than 83% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 4 consecutive years, from $10.71 in FY2021 to $17.41 in FY2025.
Based on SEC 10-K filings.
17.41 in FY2025 with a 5-year CAGR of +9.3%. Top quartile in the Health Care sector.
Increased from $13.49 to $17.41 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +9.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 156This company $17.41 Sector average $11421.56
▼
-99.8% below sector average
Key checks
Key Insights
- Quest Diagnostics's sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 16.0% year-over-year.
- Ranks #26 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.41 | +16.0% |
| FY2024 | $15.00 | +11.2% |
| FY2023 | $13.49 | +18.4% |
| FY2022 | $11.40 | +6.4% |
| FY2021 | $10.71 | -3.9% |
| FY2020 | $11.15 | +8.2% |
| FY2019 | $10.31 | +6.1% |
| FY2018 | $9.72 | -16.1% |
| FY2017 | $11.58 | -2.8% |
| FY2016 | $11.92 | +7.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026